{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:25:44Z","timestamp":1790987144862,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.jchromb.2007.01.012","type":"journal-article","created":{"date-parts":[[2007,1,19]],"date-time":"2007-01-19T07:19:16Z","timestamp":1169191156000},"page":"174-179","source":"Crossref","is-referenced-by-count":32,"title":["An optimized analytical method of fluconazole in human plasma by high-performance liquid chromatography with ultraviolet detection and its application to a bioequivalence study"],"prefix":"10.1016","volume":"852","author":[{"given":"Sung-Su","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Taek","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il-Mo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Su","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heon-Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hee","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Bin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Tae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2007.01.012_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6904-5-1","volume":"5","author":"de With","year":"2005","journal-title":"BMC Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2007.01.012_bib2","series-title":"Goodman & Gilman's The Pharmacological Basis of Therapeutics","first-page":"1225","author":"Bennets","year":"2006"},{"key":"10.1016\/j.jchromb.2007.01.012_bib3","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1128\/AAC.28.5.648","volume":"28","author":"Humphrey","year":"1985","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jchromb.2007.01.012_bib4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0378-4347(00)83458-1","volume":"383","author":"Wood","year":"1986","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.jchromb.2007.01.012_bib5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/00007691-199904000-00010","volume":"21","author":"Moraes","year":"1999","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2007.01.012_bib6","first-page":"39","volume":"42","author":"Pereira","year":"2004","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2007.01.012_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0378-4347(00)83826-8","volume":"529","author":"Hosotsubo","year":"1990","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.jchromb.2007.01.012_bib8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.5414\/CPP38355","volume":"38","author":"Manorot","year":"2000","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2007.01.012_bib9","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0731-7085(01)00686-0","volume":"28","author":"Majcherczyk","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2007.01.012_bib10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00007691-200408000-00013","volume":"26","author":"Egle","year":"2004","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2007.01.012_bib11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/bdd.443","volume":"26","author":"Al-Gaai","year":"2005","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.jchromb.2007.01.012_bib12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijpharm.2004.09.013","volume":"288","author":"Porta","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jchromb.2007.01.012_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bmc.538","volume":"20","author":"Wattananat","year":"2006","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2007.01.012_bib14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00007691-199208000-00008","volume":"14","author":"Inagaki","year":"1992","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2007.01.012_bib15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0378-4347(94)00445-B","volume":"663","author":"Koks","year":"1995","journal-title":"J. Chromatogr. B Biomed. Appl."},{"key":"10.1016\/j.jchromb.2007.01.012_bib16","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.clinthera.2005.10.016","volume":"27","author":"Jovanovic","year":"2005","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jchromb.2007.01.012_bib17","unstructured":"FDA Guidance for Industry, Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), 2001, http:\/\/www.fda.gov\/cder\/guidance\/index.htm."},{"key":"10.1016\/j.jchromb.2007.01.012_bib18","first-page":"308","volume":"44","author":"Lee","year":"2000","journal-title":"Yakhakhoeji"},{"key":"10.1016\/j.jchromb.2007.01.012_bib19","unstructured":"KFDA Guidance for Industry, Statistical Approaches to Establishing Bioequivalence, Bioequivalence Division, Pharmacology Department, National Institute of Toxicology Department, 2003, http:\/\/ezdrug.kfda.go.kr\/kfda2."},{"key":"10.1016\/j.jchromb.2007.01.012_bib20","unstructured":"FDA Guidance for Industry, Statistical Approaches to Establishing Bioequivalence, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), 2001, http:\/\/www.fda.gov\/cder\/guidance\/index.htm."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023207000578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023207000578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T16:20:54Z","timestamp":1547050854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023207000578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":20,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S1570023207000578"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2007.01.012","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}